{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:15:14Z","timestamp":1767665714850,"version":"3.41.2"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background and Objectives<\/jats:title><jats:p>APOE e4 has been linked to poor outcome following traumatic brain injury (TBI); however, the mechanisms behind this relationship are unclear. Few studies have investigated the relationship between the APOE genotype and established brain related protein biomarkers following TBI. The purpose of this study was to examine this relationship in service members and veterans (SMVs) following TBI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Participants were 209 SMVs [124 uncomplicated mild TBI (mTBI); 85 complicated mild, moderate, severe, or penetrating TBI (mod-sev TBI)] prospectively enrolled in the DVBIC-TBICoE 15-Year Longitudinal TBI Study. APOE genotyping was undertaken using non-fasting blood serum samples. Participants were divided into three groups: APOE e2+, APOE e3\/e3, and APOE e4+.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In participants with mTBI, those with the APOE e2 allele had significantly lower levels of tau than those with APOE e4 (<jats:italic>p<\/jats:italic> = 0.005, <jats:italic>r<\/jats:italic> = 0.43, medium-large effect size). Those with APOE e3\/e3 trended toward having higher tau than those APOE e2+ (<jats:italic>p<\/jats:italic> = 0.076, <jats:italic>r<\/jats:italic> = 0.20, small-medium effect size) and lower tau than those with APOE e4+ (<jats:italic>p<\/jats:italic> = 0.062, <jats:italic>r<\/jats:italic> = 0.21, small-medium effect size). There were no significant differences in biomarkers based on APOE in the mod-sev TBI group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study is the first to demonstrate APOE genotype is related to serum tau levels following a mTBI, extending prior findings to human serum following mTBI. In addition to higher serum tau levels in APOE e4 carriers, lower tau levels were observed in APOE e2 carriers, suggesting a possible protective effect.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.816625","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T04:28:07Z","timestamp":1657772887000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["APOE Is Associated With Serum Tau Following Uncomplicated Mild Traumatic Brain Injury"],"prefix":"10.3389","volume":"13","author":[{"given":"Sara M.","family":"Lippa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rael T.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifton L.","family":"Dalgard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony R.","family":"Soltis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian A.","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey A.","family":"Brickell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis M.","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/neu.2018.6052","article-title":"Apolipoprotein E4 polymorphism and outcomes from traumatic brain injury: a living systematic review and meta-analysis","volume":"38","author":"McFadyen","year":"2019","journal-title":"J Neurotrauma"},{"key":"B2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrneurol.2013.9","article-title":"Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood","volume":"9","author":"Zetterberg","year":"2013","journal-title":"Nat Rev Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ar.1091670402","article-title":"Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice","volume":"167","author":"Friede","year":"1970","journal-title":"Anat Rec."},{"key":"B4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1358\/dnp.2007.20.6.1138160","article-title":"The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders","volume":"20","author":"Gong","year":"2007","journal-title":"Drug News Perspect."},{"key":"B6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/14737159.2018.1428089","article-title":"An update on diagnostic and prognostic biomarkers for traumatic brain injury","volume":"18","author":"Wang","year":"2018","journal-title":"Expert Rev Mol Diagn."},{"key":"B7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/14728222.2017.1321635","article-title":"Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries","volume":"21","author":"Wang","year":"2017","journal-title":"Expert Opin Ther Targets."},{"key":"B8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fnagi.2017.00320","article-title":"The Decrease of Uch-L1 Activity is a common mechanism responsible for a beta 42 accumulation in Alzheimer's and vascular disease","volume":"9","author":"Guglielmotto","year":"2017","journal-title":"Front Aging Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e81249","DOI":"10.1371\/journal.pone.0081249","article-title":"Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers","volume":"8","author":"Neselius","year":"2013","journal-title":"PLoS ONE."},{"key":"B10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","article-title":"APOE and Alzheimer disease: a major gene with semi-dominant inheritance","volume":"16","author":"Genin","year":"2011","journal-title":"Mol Psychiatry."},{"key":"B11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/nan.12529","article-title":"Invited review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease","volume":"45","author":"Tzioras","year":"2019","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ana.21696","article-title":"Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age","volume":"65","author":"Kok","year":"2009","journal-title":"Ann Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer's disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, biomarkers and lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol Aging."},{"key":"B16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2174\/156720511795745375","article-title":"In vivo human amyloid imaging","volume":"8","author":"Sojkova","year":"2011","journal-title":"Curr Alzheimer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/ana.21953","article-title":"Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease","volume":"67","author":"Vemuri","year":"2010","journal-title":"Ann Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1523\/JNEUROSCI.5180-09.2010","article-title":"Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease","volume":"30","author":"Villemagne","year":"2010","journal-title":"J Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","article-title":"Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease","volume":"2","author":"Holtzman","year":"2012","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1038\/s41598-021-82901-1","article-title":"Astrocytic expression of the Alzheimer's disease risk allele, ApoEepsilon4, potentiates neuronal tau pathology in multiple preclinical models","volume":"11","author":"Jablonski","year":"2021","journal-title":"Sci Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice","volume":"24","author":"Brecht","year":"2004","journal-title":"J Neurosci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature."},{"key":"B23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","article-title":"Association of apolipoprotein E \u03b54 with medial temporal tau independent of amyloid-\u03b2","volume":"77","author":"Therriault","year":"2020","journal-title":"JAMA Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neurobiolaging.2017.04.002","article-title":"CSF ApoE predicts clinical progression in nondemented APOE\u03b54 carriers","volume":"57","author":"van Harten","year":"2017","journal-title":"Neurobiol Aging."},{"key":"B26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1326-8-16","article-title":"ApoE4 induces A\u03b242, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice","volume":"8","author":"Liraz","year":"2013","journal-title":"Mol Neurodegener."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1089\/neu.2018.6269","article-title":"Plasma tau and amyloid are not reliably related to injury characteristics, neuropsychological performance, or white matter integrity in service members with a history of traumatic brain injury","volume":"36","author":"Lippa","year":"2019","journal-title":"J Neurotrauma."},{"key":"B28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1017\/S1355617720001071","article-title":"Blood biomarkers relate to cognitive performance years after traumatic brain injury in service members and veterans","volume":"27","author":"Lippa","year":"2020","journal-title":"J Int Neuropsychol Soc"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2174\/1567205019666220330144432.","article-title":"Blood biomarkers predict future cognitive decline after military-related traumatic brain injury","author":"Lippa","year":"2022","journal-title":"Curr Alzheimer Res."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bandc.2021.105790","article-title":"Apolipoprotein E (APOE) \u03b54 genotype influences memory performance following remote TBI in military personnel","author":"Merritt","year":"2021","journal-title":"Abstract Accepted for Presentation at the American Psychological Association 2021 Virtual Meeting: Virtual"},{"key":"B31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/JSM.0b013e3181fc0a81","article-title":"Apolipoprotein E genotype and concussion in college athletes","volume":"20","author":"Tierney","year":"2010","journal-title":"Clin J Sport Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/medsci6030078","article-title":"Apolipoprotein E epsilon 4 genotype, mild traumatic brain injury, and the development of chronic traumatic encephalopathy","volume":"6","author":"Deng","year":"2018","journal-title":"Med Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1089\/neu.2016.4833","article-title":"Systematic review of genetic risk factors for sustaining a mild traumatic brain injury","volume":"34","author":"Panenka","year":"2017","journal-title":"J Neurotrauma."},{"key":"B34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/sports9020019","article-title":"Genetic factors that could affect concussion risk in elite rugby","volume":"9","author":"Antrobus","year":"2021","journal-title":"Sports (Basel, Switzerland)."},{"key":"B35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/JSM.0b013e31817e6f3e","article-title":"Does the apolipoprotein \u03b54 allele predispose varsity athletes to concussion? A prospective cohort study","volume":"18","author":"Kristman","year":"2008","journal-title":"Clin J Sport Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1089\/neu.2016.4480","article-title":"Genetics and other risk factors for past concussions in active-duty soldiers","volume":"34","author":"Dretsch","year":"2017","journal-title":"J Neurotrauma."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e00392","DOI":"10.1002\/brb3.392","article-title":"Brain-derived neurotropic factor polymorphisms, traumatic stress, mild traumatic brain injury, and combat exposure contribute to postdeployment traumatic stress","volume":"6","author":"Dretsch","year":"2016","journal-title":"Brain Behav."},{"key":"B38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jsams.2017.06.004","article-title":"An association between polymorphisms within the APOE gene and concussion aetiology in rugby union players","volume":"21","author":"Abrahams","year":"2018","journal-title":"J Sci Med Sport."},{"key":"B39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JSM.0b013e31815c1d4c","article-title":"APOE, APOE promoter, and Tau genotypes and risk for concussion in college athletes","volume":"18","author":"Terrell","year":"2008","journal-title":"Clin J Sport Med."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.816625\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T04:28:10Z","timestamp":1657772890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.816625\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":39,"alternative-id":["10.3389\/fneur.2022.816625"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.816625","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"article-number":"816625"}}